176 related articles for article (PubMed ID: 31269114)
21. The effects of icariin on wound healing of extraction sites with administration of zoledronic and dexamethasone: A rat model study.
Liu J; Mattheos N; Su C; Deng C; Luo N; Wang Z; Tang H
J Oral Pathol Med; 2018 Feb; 47(2):198-205. PubMed ID: 29130610
[TBL] [Abstract][Full Text] [Related]
22. Delayed alveolar bone repair and osteonecrosis associated with Zoledronic Acid therapy in rats: macroscopic, microscopic and molecular analysis.
Ferreira GZ; Zen Filho EV; Rubira-Bullen IRF; Garlet GP; Santos CF; Santos PSDS
J Appl Oral Sci; 2020; 28():e20200204. PubMed ID: 32997086
[TBL] [Abstract][Full Text] [Related]
23. Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw With Plasma Rich in Growth Factors After Dental Implant Surgery: A Case Report.
Gil IG; Ponte BM; Mateo ST; García JJ
J Oral Implantol; 2019 Aug; 45(4):289-296. PubMed ID: 31207196
[TBL] [Abstract][Full Text] [Related]
24. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
[TBL] [Abstract][Full Text] [Related]
25. [The role of semaphorin 4D in the mechanism of bisphosphonate-related osteonecrosis of the jaw in rats].
Pan QT; Zang XL; Sun ZW; Pan MQ; Zhu XM; Li ZY
Shanghai Kou Qiang Yi Xue; 2022 Dec; 31(6):625-631. PubMed ID: 36970799
[TBL] [Abstract][Full Text] [Related]
26. Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function.
Elsayed R; Abraham P; Awad ME; Kurago Z; Baladhandayutham B; Whitford GM; Pashley DH; McKenna CE; Elsalanty ME
Bone; 2018 May; 110():141-149. PubMed ID: 29408511
[TBL] [Abstract][Full Text] [Related]
27. Prevention of tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaws with basic fibroblast growth factor: An experimental study in rats.
Imada M; Yagyuu T; Ueyama Y; Maeda M; Yamamoto K; Kurokawa S; Jo JI; Tabata Y; Tanaka Y; Kirita T
PLoS One; 2019; 14(2):e0211928. PubMed ID: 30735554
[TBL] [Abstract][Full Text] [Related]
28. A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma.
Howie RN; Borke JL; Kurago Z; Daoudi A; Cray J; Zakhary IE; Brown TL; Raley JN; Tran LT; Messer R; Medani F; Elsalanty ME
PLoS One; 2015; 10(7):e0132520. PubMed ID: 26186665
[TBL] [Abstract][Full Text] [Related]
29. Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature.
Del Fabbro M; Gallesio G; Mozzati M
Eur J Cancer; 2015 Jan; 51(1):62-74. PubMed ID: 25466505
[TBL] [Abstract][Full Text] [Related]
30. Ozone therapy effect in medication-related osteonecrosis of the jaw as prevention or treatment: microtomographic, confocal laser microscopy and histomorphometric analysis.
Pereira-Silva M; Hadad H; de Jesus LK; de Freitas Santana Oliveira ME; de Almeida JM; Nímia HH; Magro Filho O; Okamoto R; Macedo SB; Palmieri Junior CF; Souza FÁ
Clin Oral Investig; 2024 Feb; 28(2):151. PubMed ID: 38360985
[TBL] [Abstract][Full Text] [Related]
31. Introducing a protocol to create bisphosphonate-related osteonecrosis of the jaw in rat animal model.
Zandi M; Dehghan A; Malekzadeh H; Janbaz P; Ghadermazi K; Amini P
J Craniomaxillofac Surg; 2016 Mar; 44(3):271-8. PubMed ID: 26805920
[TBL] [Abstract][Full Text] [Related]
32. Establishment of an Animal Model of Bisphosphonate-Related Osteonecrosis of the Jaws in Spontaneously Diabetic Torii Rats.
Takaoka K; Yamamura M; Nishioka T; Abe T; Tamaoka J; Segawa E; Shinohara M; Ueda H; Kishimoto H; Urade M
PLoS One; 2015; 10(12):e0144355. PubMed ID: 26659123
[TBL] [Abstract][Full Text] [Related]
33. Matrix metalloproteinase-9 expression in alveolar extraction sockets of Zoledronic acid-treated rats.
Basi DL; Hughes PJ; Thumbigere-Math V; Sabino M; Mariash A; Lunos SA; Jensen E; Gopalakrishnan R
J Oral Maxillofac Surg; 2011 Nov; 69(11):2698-707. PubMed ID: 21752506
[TBL] [Abstract][Full Text] [Related]
34. Medication-related osteonecrosis of the jaw. Introduction of a new modified experimental model.
Curra C; Cardoso CL; Ferreira O; Curi MM; Matsumoto MA; Cavenago BC; Santos PL; Santiago JF
Acta Cir Bras; 2016 May; 31(5):308-13. PubMed ID: 27275851
[TBL] [Abstract][Full Text] [Related]
35. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the therapeutic effects of conditioned media from mesenchymal stem cells in a rat bisphosphonate-related osteonecrosis of the jaw-like model.
Ogata K; Katagiri W; Osugi M; Kawai T; Sugimura Y; Hibi H; Nakamura S; Ueda M
Bone; 2015 May; 74():95-105. PubMed ID: 25613174
[TBL] [Abstract][Full Text] [Related]
37. Transplantation of Noncultured Stromal Vascular Fraction Cells of Adipose Tissue Ameliorates Osteonecrosis of the Jaw-Like Lesions in Mice.
Kuroshima S; Sasaki M; Nakajima K; Tamaki S; Hayano H; Sawase T
J Bone Miner Res; 2018 Jan; 33(1):154-166. PubMed ID: 28902422
[TBL] [Abstract][Full Text] [Related]
38. Zoledronate induces osteonecrosis of the jaw in sheep.
Voss PJ; Stoddart M; Ziebart T; Zeiter S; Nelson K; Bittermann G; Schmelzeisen R; Poxleitner P
J Craniomaxillofac Surg; 2015 Sep; 43(7):1133-8. PubMed ID: 26154396
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice.
Kuroshima S; Sasaki M; Nakajima K; Tamaki S; Hayano H; Sawase T
Bone; 2018 Jul; 112():177-186. PubMed ID: 29729428
[TBL] [Abstract][Full Text] [Related]
40. Nitrogen-containing bisphosphonate therapy: assessment of the alveolar bone structure in rats - a blind randomized controlled trial.
Pacheco VN; Langie R; Etges A; Ponzoni D; Puricelli E
Int J Exp Pathol; 2015 Aug; 96(4):255-60. PubMed ID: 26119047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
